Ella Richardson, Shamila Griffiths, Sharon Rowton, Christopher Smith
{"title":"Evaluation of the head twitch response in male C57BL/6J mice as a measure of 5-HT2a receptor activation","authors":"Ella Richardson, Shamila Griffiths, Sharon Rowton, Christopher Smith","doi":"10.1016/j.vascn.2025.107622","DOIUrl":null,"url":null,"abstract":"<div><div>The head twitch response (HTR) is a rhythmic paroxysmal rotational head movement that occurs in mice following 5-HT<sub>2A</sub> receptor activation. This test may be used to evaluate the potential for novel drugs to activate the 5-HT<sub>2A</sub> receptor, to produce a synergistic effect when co-administered with medications which elevate serotonin levels or antagonize hallucinogenic-like behavior for the purpose of treating aspects of brain disorders, including positive symptoms of Schizophrenia. The HTR was characterized in male C57BL/6J mice using psilocybin (0.5 to 2 mg/kg, IP), psilocin (0.3 to 1.0 mg/kg, IP), LSD (0.05 to 0.2 mg/kg, IP) and DOI (0.25 to 1.0 mg/kg, IP). Immediately following administration, mice were placed into observation chambers and observed continuously for 60 min. The number of head twitches were recorded in 10-min bins. Head twitch was observed in all treatment groups and varied in terms of frequency and time of peak effect. DOI produced an inverted ‘<em>U</em>'-shaped dose response, peaking between 21 and 30 min postdose, with a group total of 85 head twitches (0.5 mg/kg). Psilocybin and psilocin (the pharmacologically active agent of psilocybin) produced a dose-related response, peaking between 11 and 20 and 0 and 10 min postdose, respectively, with a group total of 70 (2 mg/kg) and 55 (1 mg/kg) head twitches, respectively. LSD produced a dose-related response, peaking between 11 and 20 min postdose, with a group total of 63 head twitches (0.2 mg/kg). For the purpose of characterizing attenuation of the HTR, clozapine (atypical antipsychotic) at 1.25 to 5.0 mg/kg, IP or haloperidol (typical antipsychotic) at 0.15 to 0.6 mg/kg, IP, were administered to mice. Thirty minutes later, the hallucinogen DOI (0.5 mg/kg, IP) was administered to induce the HTR. Animals were observed continuously for 30 min from 10 min post-DOI administration. Clozapine (1.25 mg/kg) and haloperidol (0.6 mg/kg) attenuated HTR by 68 and 64 %, respectively, when compared to DOI alone. Clozapine (2.5 and 5 mg/kg) attenuated the HTR, however the animals were highly sedated. These findings validated the HTR test in male C57BL/6J mice.</div></div>","PeriodicalId":16767,"journal":{"name":"Journal of pharmacological and toxicological methods","volume":"133 ","pages":"Article 107622"},"PeriodicalIF":1.3000,"publicationDate":"2025-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of pharmacological and toxicological methods","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S1056871925000425","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"PHARMACOLOGY & PHARMACY","Score":null,"Total":0}
引用次数: 0
Abstract
The head twitch response (HTR) is a rhythmic paroxysmal rotational head movement that occurs in mice following 5-HT2A receptor activation. This test may be used to evaluate the potential for novel drugs to activate the 5-HT2A receptor, to produce a synergistic effect when co-administered with medications which elevate serotonin levels or antagonize hallucinogenic-like behavior for the purpose of treating aspects of brain disorders, including positive symptoms of Schizophrenia. The HTR was characterized in male C57BL/6J mice using psilocybin (0.5 to 2 mg/kg, IP), psilocin (0.3 to 1.0 mg/kg, IP), LSD (0.05 to 0.2 mg/kg, IP) and DOI (0.25 to 1.0 mg/kg, IP). Immediately following administration, mice were placed into observation chambers and observed continuously for 60 min. The number of head twitches were recorded in 10-min bins. Head twitch was observed in all treatment groups and varied in terms of frequency and time of peak effect. DOI produced an inverted ‘U'-shaped dose response, peaking between 21 and 30 min postdose, with a group total of 85 head twitches (0.5 mg/kg). Psilocybin and psilocin (the pharmacologically active agent of psilocybin) produced a dose-related response, peaking between 11 and 20 and 0 and 10 min postdose, respectively, with a group total of 70 (2 mg/kg) and 55 (1 mg/kg) head twitches, respectively. LSD produced a dose-related response, peaking between 11 and 20 min postdose, with a group total of 63 head twitches (0.2 mg/kg). For the purpose of characterizing attenuation of the HTR, clozapine (atypical antipsychotic) at 1.25 to 5.0 mg/kg, IP or haloperidol (typical antipsychotic) at 0.15 to 0.6 mg/kg, IP, were administered to mice. Thirty minutes later, the hallucinogen DOI (0.5 mg/kg, IP) was administered to induce the HTR. Animals were observed continuously for 30 min from 10 min post-DOI administration. Clozapine (1.25 mg/kg) and haloperidol (0.6 mg/kg) attenuated HTR by 68 and 64 %, respectively, when compared to DOI alone. Clozapine (2.5 and 5 mg/kg) attenuated the HTR, however the animals were highly sedated. These findings validated the HTR test in male C57BL/6J mice.
期刊介绍:
Journal of Pharmacological and Toxicological Methods publishes original articles on current methods of investigation used in pharmacology and toxicology. Pharmacology and toxicology are defined in the broadest sense, referring to actions of drugs and chemicals on all living systems. With its international editorial board and noted contributors, Journal of Pharmacological and Toxicological Methods is the leading journal devoted exclusively to experimental procedures used by pharmacologists and toxicologists.